{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["22(9)"],"submitter":["Kakuru A"],"funding":["Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases","NIAID NIH HHS"],"journal":["PLoS medicine"],"pagination":["e1004582"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12445490"],"repository":["biostudies-literature"],"pubmed_title":["Dihydroartemisinin-piperaquine plus sulfadoxine-pyrimethamine versus either drug alone for intermittent preventive treatment of malaria in pregnancy: A double-blind, randomized, controlled phase 3 trial from Uganda."],"pmcid":["PMC12445490"],"funding_grant_id":["U01 AI141308","U01AI141308"],"pubmed_authors":["Dela Cruz E","Adrama H","Jagannathan P","Gaw SL","Nakalembe M","Ozarslan N","Kamya MR","Aguti M","Ranjit A","Ategeka J","Clark TD","Olwoch P","Roh ME","Kakuru A","Dorsey G","Kizza J","Opira B","Rosenthal PJ","Nankabirwa JI"],"additional_accession":[]},"is_claimable":false,"name":"Dihydroartemisinin-piperaquine plus sulfadoxine-pyrimethamine versus either drug alone for intermittent preventive treatment of malaria in pregnancy: A double-blind, randomized, controlled phase 3 trial from Uganda.","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-06-04T07:28:31.089Z","creation":"2026-06-04T03:05:49.603Z"},"accession":"S-EPMC12445490","cross_references":{"pubmed":["40966190"],"doi":["10.1371/journal.pmed.1004582"]}}